# Multicenter Pilot Study To Define The Marker As An Alternate For Tropism Assay

> **NCT00496782** · PHASE1 · TERMINATED · sponsor: **ViiV Healthcare** · enrollment: 16 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** maraviroc
- **PROCEDURE:** Trofile Assay and HIV RNA quantification assay

## Key facts

- **NCT ID:** NCT00496782
- **Lead sponsor:** ViiV Healthcare
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-07
- **Primary completion:** 2008-10
- **Final completion:** 2008-10
- **Target enrollment:** 16 (ACTUAL)
- **Why stopped:** See Detailed Description
- **Last updated:** 2019-01-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00496782

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00496782, "Multicenter Pilot Study To Define The Marker As An Alternate For Tropism Assay". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00496782. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*